Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04746014 · ClinicalTrials.gov registry record
Clearblue Pregnancy Test Lay User Usage Study
A clinical trial, sponsored by SPD Development Company Limited.
- Completed
- Registry status
- 306
- Enrollment target
NCT04746014: Completed study, sponsored by SPD Development Company Limited.
NCT04746014 is a clinical trial that has completed, run by SPD Development Company Limited. The registered enrollment target is 306 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04746014 has completed, sponsored by SPD Development Company Limited.
- COMPLETED
- Registry status
- 306 participants
- Enrollment target
Study Summary
The Clearblue home pregnancy test (HPT) is an over the counter urine hCG (human chorionic gonadotrophin) visual pregnancy test which is intended for the detection of pregnancy. This study will assess the performance of the HPT in the hands of the lay user by comparing their results when used according to the instructions for use (IFU) to (i) confirmed pregnancy status of the volunteers and (ii) to the results of trained study staff testing the same urine samples.
Primary Outcome
Number of pregnancy tests in agreement with pregnancy status
Interventions
- DIAGNOSTIC_TEST Clearblue Pregnancy Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 306 participants |
| Start Date | 2021-02-09 |
| Est. Completion | 2021-08-03 |
What the finished NCT04746014 record still lists
NCT04746014 is an observational study that tracks outcomes without assigning an intervention. The registered 306 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Clearblue Pregnancy Test is the first listed.
NCT04746014 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04746014 about?
NCT04746014 is a clinical study titled "Clearblue Pregnancy Test Lay User Usage Study". The Clearblue home pregnancy test (HPT) is an over the counter urine hCG (human chorionic gonadotrophin) visual pregnancy test which is intended for the detection of pregnancy. This study will assess the performance of the HPT in the hands of the lay user by comparing their results when used accordi...
What is the current status of trial NCT04746014?
This trial is currently completed. The enrollment target is 306 participants. The study started on 2021-02-09. Estimated completion is 2021-08-03.
What interventions are being tested in trial NCT04746014?
The interventions under investigation include: Clearblue Pregnancy Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04746014?
This trial is sponsored by SPD Development Company Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05078970 · 306 participants · NA
Advancing Suicide Intervention Strategies for Teens During High Risk Periods
- NCT05843695 · 306 participants · NA
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
- NCT06057337 · 306 participants · NA
Families With Pride ("Familias Con Orgullo").
- NCT06498635 · 306 participants · Phase 3
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI